Bicyclic AZA compounds as muscarinic M1 receptor antagonists
US9975890B2 · kind B2 · utility
10Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 15, 2017 |
| Grant date | May 22, 2018 |
| Priority date | — |
| Expiry date | May 15, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds (Formula (1)) that are agonists of the muscarinic M1 receptor and which are useful in the treatment of muscarinic M1 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds provided are of formula where R1-R5, X1, X2 and p are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.